Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension
Clinical trial NCT01523067 · COMPLETED
Trial details
- NCT number
- NCT01523067
- Sponsor
- PhaseBio Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2012-12-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.